BHIC · BioScience Health Innovations, Inc. · Executive Compensation
Market Cap
$88.44M
Shares
11.75M
Volume · Sep 29
2731
Avg daily vol (3M)
4384
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel Schmidt | director | Appointed | 2026-04-02 |
| Justin Earl | Board of Directors | Resigned | 2026-04-02 |
| John Chymboryk | Chief Financial Officer | Appointed | 2023-03-23 |
| Darren López | Chief Executive Officer | Appointed | 2023-03-16 |
| John Chymboryk | Director | Appointed | 2023-03-16 |
| Darren Lopez | Director | Appointed | 2023-03-16 |